Back to results
US 2019/0161481 A1Published application
Novel (Cyano-Dimethyl-Methyl)-Isoxazoles and -[1,3,4]Thiadiazoles
AssigneeCentrexion Therapeutics Corporation
InventorsDoris Riether, Florian Paul Christian Binder, Henri Doods, Stephan Georg Mueller, Janet Rachel Nicholson, Achim Sauer
Life of this patent
Estimating the term…
Abstract
This invention relates to novel (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles and their use as CB2 cannabinoid receptor agonists, pharmaceutical compositions containing the same, and their use for the treatment of CB2 receptor mediated disorders or conditions.
Claims21
1-6. (canceled)
A method of activating a cannabinoid receptor 2 in a human being experiencing pain, comprising administering to the human being an effective amount of a compound selected from the group consisting of
- and a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.